Compound information
- Natural Products
- ZC1570786
- Molecular Formula
- C20H20ClN3O4S
- Molecular Weight
- 433.0863048 g/mol
- Structure
-
- IUPAC Name
- N-[4-[4-(4-chlorophenyl)sulfonylpiperazine-1-carbonyl]phenyl]prop-2-enamide
- InChI
- InChI=1S/C20H20ClN3O4S/c1-2-19(25)22-17-7-3-15(4-8-17)20(26)23-11-13-24(14-12-23)29(27,28)18-9-5-16(21)6-10-18/h2-10H,1,11-14H2,(H,22,25)
- InChI Key
- KWBKKQAERAVFPI-UHFFFAOYSA-N
- SMILES
- C=CC(=O)Nc1ccc(C(=O)N2CCN(S(=O)(=O)c3ccc(Cl)cc3)CC2)cc1
- Source
- ZINC000917565484
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 29 | Ring Count | 3 |
Heteroatom Count | 9 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 86.79 Å2 | LogP | 2.575 |
LogS | -4.326 | LogD | 2.912 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.016 | Pgp substrate | 0.233 |
HIA | 0.966 | F20 % | 0.99 |
F30 % | 0.188 | Caco-2 | -4.557 |
MDCK | -4.957 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.057 | PPB | 94.503 |
VD | 0.552 | Fu | 1.786 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.043 | CYP1A2 substrate | 0.582 |
CYP2A6 substrate | 0.447 | CYP2B6 substrate | 0.542 |
CYP2C19 inhibitor | 0.372 | CYP2C19 substrate | 0.801 |
CYP2C8 substrate | 0.838 | CYP2C9 inhibitor | 0.565 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.017 |
CYP2D6 substrate | 0.922 | CYP2E1 substrate | 0.863 |
CYP3A4 inhibitor | 0.072 | CYP3A4 substrate | 0.998 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.134 | CL | 0.593 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.11 | Hepatotoxicity | 0.742 |
Mutagenicity | 0.007 | Rat Oral Acute Toxicity | 0.118 |
FDAMDD | 0.299 | Skin Sensitization | 0.001 |
Carcinogenicity | 0.416 | Eye Corrosion | 0.004 |
Eye Irritation | 0.052 | Respiratory Toxicity | 0.005 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.615 | IGC50 | 3.983 |
LC50FM | -7.14 | LC50DM | -3.012 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.099 | NR-AR-LBD | 0.423 |
NR-AhR | 0.24 | NR-Aromatase | 0.101 |
NR-ER | 0.446 | NR-ER-LBD | 0.511 |
NR-PPAR-gamma | 0.447 | SR-ARE | 0.869 |
SR-ATAD5 | 0.429 | SR-HSE | 0.099 |
SR-MMP | 0.263 | SR-p53 | 0.295 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.